Metastatic Non-Small Cell Lung Cancer 2024 UPDATE
Two Onc Docs
00:00
Treatment Options and Molecular Testing in Metastatic Non-Small Cell Lung Cancer
This chapter explores treatment options for metastatic non-small cell lung cancer, focusing on the importance of PD-L1 testing for immunotherapy eligibility. It reviews chemotherapy alternatives, recent FDA approvals, and the vital role of molecular testing in guiding personalized therapy decisions.
Transcript
Play full episode
